• babban_banner_01

Kayayyaki

  • Babban Tsabta Peptides Retatrutide 10mg don Rage nauyi da Ciwon sukari

    Babban Tsabta Peptides Retatrutide 10mg don Rage nauyi da Ciwon sukari

    Tsafta:> 99%

    Jiha: Lyophilized Foda

    Bayyanar: Farin foda

    Musamman: 5mg/10mg/15mg/20mg/30mg

  • Retatrutide

    Retatrutide

    Retaglutide shine sabon dipeptidyl peptidase-4 (DPP-4) inhibitor aji hypoglycemic magani wanda zai iya hana lalata glucagon-kamar peptide-1 (GLP-1) da kuma glucose-dogara insulin-releasing polypeptide (GIP) ta DPP-4 enzyme a cikin hanji da jini, tsawanta pancreatic sel ta hanyar pancreatic insulin. Basal matakin insulin mai azumi, yayin da yake rage fitowar glucagon ta ƙwayoyin α pancreatic, ta haka zai fi dacewa da sarrafa sukarin jini na postprandial. Yana aiki da kyau dangane da tasirin hypoglycemic, haƙuri, da yarda.

  • Ciwon sodium

    Ciwon sodium

    Inclisiran sodium API (Active Pharmaceutical Ingredient) ana nazarinsa da farko a fagen tsoma bakin RNA (RNAi) da kuma hanyoyin kwantar da hankali na zuciya. A matsayin siRNA mai madauri biyu da ke niyya ga kwayar PCSK9, ana amfani da shi a cikin bincike na gaskiya da na asibiti don kimanta dabarun yin shiru na dogon aiki don rage LDL-C (cholesterol mai ƙarancin yawa). Hakanan yana aiki azaman abin ƙira don bincika tsarin isar da siRNA, kwanciyar hankali, da magungunan RNA mai niyya da hanta.

  • Fmoc-Gly-Gly-OH

    Fmoc-Gly-Gly-OH

    Fmoc-Gly-Gly-OH dipeptide ne da aka yi amfani da shi azaman tushen ginin gini a cikin haɗakar peptide mai ƙarfi (SPPS). Yana fasalta ragowar glycine guda biyu da kuma N-terminus mai kariya ta Fmoc, yana ba da izinin haɓaka sarkar peptide mai sarrafawa. Saboda ƙananan girman glycine da sassauci, ana yin nazarin wannan dipeptide sau da yawa a cikin mahallin motsin kashin baya na peptide, ƙirar haɗin gwiwa, da ƙirar ƙirar tsari a cikin peptides da sunadarai.

     

  • Fmoc-Thr(tBu) -Phe-OH

    Fmoc-Thr(tBu) -Phe-OH

    Fmoc-Thr(tBu) -Phe-OH tubalin ginin dipeptide ne wanda aka saba amfani dashi a cikin hadadden peptide synthesis (SPPS). Ƙungiyar Fmoc (9-fluorenylmethyloxycarbonyl) tana kare N-terminus, yayin da ƙungiyar tBu (tert-butyl) ke kare sarkar gefen hydroxyl na threonine. Ana nazarin wannan kariya ta dipeptide don rawar da yake takawa wajen sauƙaƙe haɓakar haɓakar peptide mai inganci, rage tseren tsere, da ƙirar ƙayyadaddun ƙayyadaddun jigogi a cikin tsarin furotin da nazarin hulɗa.

  • AEEA-AEEA

    AEEA-AEEA

    AEEA-AEEA hydrophilic ne, mai sassauƙan sararin samaniya wanda aka saba amfani dashi a cikin binciken peptide da haɗin gwiwar ƙwayoyi. Ya ƙunshi raka'a biyu na tushen ethylene glycol, yana mai da amfani don nazarin tasirin haɗin haɗin gwiwa da sassauci akan hulɗar kwayoyin halitta, solubility, da ayyukan nazarin halittu. Masu bincike sukan yi amfani da sassan AEEA don tantance yadda masu sararin samaniya ke yin tasiri ga ayyukan haɗin gwiwar magungunan antibody-drug (ADCs), peptide-drog conjugates, da sauran bioconjugates.

  • Fmoc-L-Lys[Eic(OtBu)-γ-Glu(OtBu)-AEEA]-OH

    Fmoc-L-Lys[Eic(OtBu)-γ-Glu(OtBu)-AEEA]-OH

    Wannan fili shine kariyar lysine mai aiki, wanda aka yi amfani da shi a cikin haɗin peptide da haɓaka haɗin magunguna. Yana fasalta ƙungiyar Fmoc don kariyar N-terminal, da gyare-gyare na gefe tare da Eic (OtBu) (eicosanoic acid derivative), γ-glutamic acid (γ-Glu), da AEEA (aminoethoxyethoxyacetate). An ƙera waɗannan abubuwan haɗin gwiwa don nazarin tasirin lipidation, sinadarai ta sarari, da sakin magunguna masu sarrafawa. An yi bincike sosai a cikin mahallin dabarun samar da magunguna, masu haɗin ADC, da peptides masu mu'amala da membrane.

     

  • Fmoc-L-Lys[Ste(OtBu)-γ-Glu-(OtBu)-AEEA-AEEA]-OH

    Fmoc-L-Lys[Ste(OtBu)-γ-Glu-(OtBu)-AEEA-AEEA]-OH

    Wannan fili wani nau'in lysine ne da aka gyara wanda aka yi amfani da shi a cikin haɗin peptide, musamman don gina haɗin gwiwar peptide da aka yi niyya ko multifunctional. Ƙungiyar Fmoc tana ba da damar yin kira ta hanyar mataki ta hanyar Fmoc solid-phase peptide synthesis (SPPS). An gyaggyara sarkar gefen tare da stearic acid wanda aka samu (Ste), γ-glutamic acid (γ-Glu), da masu haɗin AEEA guda biyu (aminoethoxyethoxyethoxyacetate), waɗanda ke ba da hydrophobicity, kaddarorin caji, da tazara mai sassauƙa. Ana yawan nazarin shi don rawar da yake takawa a cikin tsarin isar da magunguna, gami da haɗin gwiwar magungunan rigakafi (ADCs) da peptides masu shiga tantanin halitta.

  • Liraglutide Anti-Diabetics don Kula da Sugar Jini CAS NO.204656-20-2

    Liraglutide Anti-Diabetics don Kula da Sugar Jini CAS NO.204656-20-2

    Abunda yake aiki:Liraglutide (analog na ɗan adam glucagon-kamar peptide-1 (GLP-1) wanda yisti ke samarwa ta hanyar fasahar sake haɗuwa da kwayoyin halitta).

    Sunan Sinadari:Arg34Lys26-(N-ε-(γ-Glu(N-α-hexadecanoyl))) -GLP-1[7-37]

    Sauran Sinadaran:Disodium Hydrogen Phosphate Dihydrate, Propylene Glycol, Hydrochloric Acid da/ko Sodium Hydroxide (a matsayin pH Adjusters Only), Phenol, da Ruwa don allura.

  • Leuprorelin Acetate Yana Gudanar da Sigar Hormones na Gonadal

    Leuprorelin Acetate Yana Gudanar da Sigar Hormones na Gonadal

    Suna: Leuprorelin

    Lambar CAS: 53714-56-0

    Tsarin kwayoyin halitta: C59H84N16O12

    Nauyin Kwayoyin: 1209.4

    Lambar EINECS: 633-395-9

    Takamaiman juyawa: D25 -31.7° (c = 1 cikin 1% acetic acid)

    Yawan yawa: 1.44± 0.1 g/cm3(an annabta)

  • Boc-His(Trt)-Aib-Gln(Trt)-Gly-OH

    Boc-His(Trt)-Aib-Gln(Trt)-Gly-OH

    Boc-His(Trt)-Aib-Gln(Trt)-Gly-OHwani tetrapeptide mai kariya ne da ake amfani dashi a cikin haɗin peptide da nazarin tsarin. Ƙungiyar Boc (tert-butyloxycarbonyl) tana kare N-terminus, yayin da ƙungiyoyin Trt (tryl) ke kare sassan sassan histidine da glutamine don hana halayen da ba a so. Kasancewar Aib (α-aminoisobutyric acid) yana haɓaka haɓakar haɓakar helical kuma yana haɓaka kwanciyar hankali na peptide. Wannan peptide yana da kima don bincikar nadawa peptide, kwanciyar hankali, da kuma a matsayin siffa don zayyana peptides masu aiki da ilimin halitta.

  • Saukewa: BPC-157

    Saukewa: BPC-157

    API ɗin BPC-157 yana ɗaukar ingantaccen tsarin haɗin lokaci (SPPS):
    Babban tsabta: ≥99% (Gano HPLC)
    Ragowar ƙazanta maras nauyi, babu endotoxin, babu gurɓataccen ƙarfe
    Tsayayyen tsari, maimaituwa mai ƙarfi, goyan bayan amfani matakin allura
    Taimakawa samar da matakan gram da kilogiram don biyan bukatun matakai daban-daban daga R&D zuwa masana'antu.